Viewing Study NCT01217450


Ignite Creation Date: 2025-12-24 @ 5:05 PM
Ignite Modification Date: 2025-12-29 @ 5:35 PM
Study NCT ID: NCT01217450
Status: COMPLETED
Last Update Posted: 2014-05-29
First Post: 2010-10-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Selumetinib and Cetuximab in Treating Patients With Refractory Solid Tumors
Sponsor: National Cancer Institute (NCI)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module